Home Tags CORO


Schizophrenia Tied to Higher Risk for Severe COVID-19

Risk higher despite lower infection risk and regardless of sociodemographic and medical factors

mRNA-1273 Continues to Be Efficacious at Five Months

Vaccine efficacy was 93.2 percent for preventing COVID-19 illness, 98.2 percent for preventing severe COVID-19

CDC Endorses Booster Shots for Millions of Americans

Recommendations came just one day after the FDA authorized boosters for several vulnerable groups at least six months after the second dose

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Guillain-Barré Syndrome May Be Triggered by SARS-CoV-2 Infection

During study period, 22 percent with GBS had confirmed or probable SARS-CoV-2 infection; patients had uniform neurologic features

Antibodies ID’d in Neonates of Women Vaccinated Against COVID-19

All 36 neonates had high levels of anti-S IgG; in 34 of 36 neonates, levels exceeded 250 U/mL

WHO Issues Guidance for Use of Casirivimab-Imdevimab in COVID-19

Combo conditionally recommended for patients with nonsevere disease at risk for severe disease, seronegative patients with severe infection

FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans

Exactly who qualifies as high risk because of health or work reasons is not yet clear

Uptake Low for Monoclonal Antibodies for COVID-19

Use peaked in January and declined in early 2021, at the time of the vaccine rollout

COVID-19 Does Not Seem to Impact Lung Function in Young People

No statistically significant deterioration in lung function seen following COVID-19, regardless of severity